| HOME >> BIOLOGY >> TECHNOLOGY |
SHANGHAI, China, May 9 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced it completed the foundation work for its new plant at Qing Pu, Shanghai.
"The new plant which has a 150 MT capacity is the cornerstone of our growth strategy. We have put over 1,000 pilings in the ground over the last couple of months. We are pleased that the piling work is complete and we have laid a solid foundation on which to build this plant," said Mr. Jinan Song, Chairman and Chief Executive Officer of China-Biotics. "We have started building the factory infrastructure which we hope to complete by the end of third quarter this year. We have already placed orders for all major equipment that we need."
"The new plant has a steel structure and the equipment will also be largely made of steel. With rising Renminbi and steel prices, the construction costs are expected to escalate. Despite this, we believe that our new plant will remain one of the cheapest of its kind," said Mr. Song. "When completed during the 2009 fiscal year, it will be the only large-scale probiotics plant in China that supplies the domestic bulk additive market."
About China-Biotics, Inc.
Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the
Company") was founded in 1999 and is one of China's largest suppliers of
probiotics. Probiotics are beneficial live bacteria used as dietary
supplements and food additives to improve intestinal health and digestion.
The Company's product portfolio contains live microbials made with
proprietary technology. Currently, these products are sold over-the-counter
under the "Shining" brand through large distributors to more than 1,000
pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining
is one of the most recognized
'/>"/>
| SOURCE China-Biotics, Inc. Copyright©2008 PR Newswire. All rights reserved |